Synapse

← Donald E. Cutlip

Papers by Donald E. Cutlip

Page 3 · newest first

  1. Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting StentsCirculation · 2009
  2. Multivessel drug‐eluting stenting and impact of diabetes mellitus—A report from the EVENT registryCatheterization and Cardiovascular Interventions · 2008
  3. Drug-Eluting or Bare-Metal Stents for ST Elevation Myocardial Infarction Can Observational Data Balance the Risk Benefit Equation?Circulation Cardiovascular Interventions · 2008
  4. Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary InterventionCirculation · 2008
  5. Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysisHeart · 2008
  6. Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk PatientsNew England Journal of Medicine · 2008
  7. Saphenous Vein Graft Stenting and Major Adverse Cardiac EventsCirculation · 2008
  8. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromesPostgraduate Medical Journal · 2008
  9. Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent ImplantationCirculation · 2007
  10. Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney diseaseNephrology Dialysis Transplantation · 2007
  11. Clinical End Points in Coronary Stent TrialsCirculation · 2007
  12. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting StentsNew England Journal of Medicine · 2007
  13. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine · 2007
  14. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine · 2007
  15. Current Issues in Coronary Artery Stenting in the ElderlyAging Health · 2007
  16. Drug-eluting stent era: will we improve 5-year outcomes?Coronary Artery Disease · 2006
  17. Hospital Delays in Reperfusion for ST-Elevation Myocardial InfarctionCirculation · 2006
  18. Drug-eluting stent era: will we improve 5-year outcomes?Coronary Artery Disease · 2006
  19. Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized TrialsCirculation · 2005
  20. Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting StentsCirculation · 2005
  21. Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk PatientsNew England Journal of Medicine · 2004
  22. Beyond RestenosisCirculation · 2004
  23. Drug‐eluting stent task force: Final report and recommendations of the working committees on cost‐effectiveness/economics, access to care, and medicolegal issuesCatheterization and Cardiovascular Interventions · 2004
  24. Stent Thrombosis After Successful Sirolimus-Eluting Stent ImplantationCirculation · 2004
  25. Analysis of 1-Year Clinical Outcomes in the SIRIUS TrialCirculation · 2004
  26. Incidence and predictors of late total occlusion following coronary stentingCatheterization and Cardiovascular Interventions · 2003
  27. Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass GraftsCirculation · 2002
  28. Impact of Smoking on Clinical and Angiographic Restenosis After Percutaneous Coronary InterventionCirculation · 2001
  29. Stent Thrombosis in the Modern EraCirculation · 2001
  30. Impact of Smoking on Health-Related Quality of Life After Percutaneous Coronary RevascularizationCirculation · 2000
  31. Percutaneous Coronary Revascularization in Elderly Patients: Impact on Functional Status and Quality of LifeAnnals of Internal Medicine · 2000
  32. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens After Coronary Artery StentingSurvey of Anesthesiology · 1999
  33. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine · 1998
  34. ‘Optimal’ Directional Coronary AtherectomyCirculation · 1998
  35. Final Results of the Balloon vs Optimal Atherectomy Trial (BOAT)Circulation · 1998
  36. Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phaseCoronary Artery Disease · 1996